Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.69 USD | +2.97% | -2.03% | -10.01% |
06-18 | Stifel Initiates Celldex Therapeutics at Buy Rating With $58 Price Target | MT |
06-11 | Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.01% | 2.35B | |
+35.14% | 51.51B | |
-7.43% | 39.03B | |
+34.15% | 38.91B | |
-10.62% | 26.68B | |
+11.63% | 26.13B | |
-17.77% | 19.91B | |
+40.52% | 13.71B | |
+30.70% | 12.38B | |
-3.41% | 11.74B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Gerald McMahon Resigns from the Board of Celldex Therapeutics, Inc